Orthopedics Articles

Orthopedics

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bone H et al. – 2 years of weekly odanacatib treatment was generally well–tolerated and increased lumbar spine and total hip BMD in a dose–related manner in postmenopausal women with low BMD.

Related Articles

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Therapeutics and Clinical Risk Management, 10/16/09    Relevance Score: 69%

Combination of Two Medications Help Postmenopausal Women with Osteoporosis
MedLinePlus, 10/30/09    Relevance Score: 68%

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09    Relevance Score: 67%

Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Journal of Clinical Endocrinology and Metabolism, 11/10/09    Relevance Score: 67%

Bazedoxifene acetate: A novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis
Drugs of Today, 11/05/09    Relevance Score: 67%

Today in Clinical Pharmacology...keeping you current

Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09

Postoperative analgesic effect of preoperative intravenous flurbiprofen in arthroscopic rotator cuff repair
Journal of Anesthesia, 11/24/09

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
Canadian Medical Association Journal, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address